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INTRODUCTION
Alterations in glucose metabolism have been observed
to occur in a variety of infectious processes such as endotoxemia and septicemia.

The metabolic response to infec-

tion is characterized by a biphasic pattern in plasma glucose levels.

The hyperglycemia manifested in early endo-

toxemia or sepsis has been attributed to an increase in hepatic gluconeogenesis, glycogenolysis and increased availability of gluconeogenic substrates, such as alanine and
lactate.

This primarily catabolic response has been as-

cribed to an elevation in glucagon, catecholamine, glucocorticoid and growth hormone levels.
In contrast, the terminal stage of gram negative
sepsis and endotoxicosis is marked by a state of progressive hyperinsulinism which,

if left unchecked,

leads to profound hypoglycemia and death.

inevitably

Three basic

mechanisms have been thought to contribute to this energy
substrate depletion.

Firstly,

the increase in hepatic

glycogenolysis is a transient one.

The prolonged and

heightened sympathetic drive exhausts the available glycogen stores early in the infectious process.

Second, and

perhaps more important in the progression to hypoglycemia,
is the depression of hepatic gluconeogenesis.
1

Lastly,

the

2
increased disappearance of glucose from the body glucose
pool, i.e., enhanced peripheral tissue glucose oxidation.
The latter is of particular interest in this study.
It has been shown that different components of the
body act as glucose sinks in the agonal stages of endotoxin and septic shock.

The liver, diaphragm,

spleen,

epididymal fat pads and certain blood components have all
been demonstrated to increase their energy expenditure
during the infectious process.

Work from this laboratory

has shown that in endotoxemia, the sensitivity of adipose
tissue to a given stimulus of insulin is elevated.

Whether

the same is true in experimental septic shock is a question
that this study will seek to address.
Recent work from our laboratory has suggested another
factor which may partially explain the increase in glucose
utilization; non-suppressible insulin-like activity (NSILA).
NSILA in the serum is a glycoprotein of non-pancreatic
origin and is physicochemically distinct from insulin.

An

increase in NSILA levels has been demonstrated to occur in
rats in late endotoxic shock (14).

This increase was ac-

companied by hypoglycemia and hypoinsulinema.
This study will also investigate the role of NSILA
in the septic shock syndrome.

Whether it contributes to

the progression of hypoglycemia by altering tissue glucose
will be ascertained.

LITERATURE REVIEW
A survey by Martin (40) in 1969 revealed a disturbing
trend in the frequency of bacteremias in American hospitals.
By his estimate, in 1968, 1% of hospital admissions developed bacteremia and 60% of these were due to gram negative bacteria.

At least 250,000 cases of infection oc-

curred leading to approximately 50,000 deaths.

A more

recent estimate by Wolff and Bennett (75) in 1974 puts the
number of documented cases of gram negative sepsis at
71,000 per year with a resultant 18,000 deaths.

In yet

another study dealing with postoperative sepsis and total
hospital infection rate, 3.9% of surgical patients developed postoperative sepsis and 13.5% was the total infection
rate (72).

McCabe (42) has shown that the incidence of sep-

sis has increased arithmetically over 2 decades until 1974.
Clearly, the frequency of sepsis has been on the rise
due to the increasing proportion of elderly, chronically
ill patients, increased number and complexity of surgical
operations, ineffective antibiotic therapy, etc.

This

alarming fact has spurred the progression of ventures into
This study will be concern-

the various facets of sepsis.

ed primarily with alterations in carbohydrate metabolism
in the late stage of sepsis.
3
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The metabolic response to infection is a dynamic
process.

It is influenced by a number of factors includ-

ing the severity and duration of illness, microorganism
type, and physiological status of the host.

These re-

sponses may also exhibit interrelated biphasic patterns.
Generally,
bolic one.

the early response to infection is a cata-

Gluconeogenesis is enhanced during sepsis by

the stimulatory action of hormones and by the increased
availability of gluconeogenic substrates ( 2).

This early

phase is analogous to Cuthberson's "flow" phase (12).
This catabolic or flow phase of injury or infection is
characterized by an increase in the metabolic rate, body
temperature, serum insulin, catecholamine, glucose, glucocorticoid, growth hormone and lactate concentrations
( 6 2) •

If the infectious process is severe or is unchecked

and allowed to continue, an irreversible transition to a
shock state occurs and death inevitably ensues.

A marked

hypoglycemia is characteristic of this agonal stage of infection and injury.

HYPOGLYCEMIA IN INFECTION
Terminal hypoglycemia has been demonstrated in humans
and a wide variety of animals including dogs, monkeys and
rats during septic and endotoxemic episodes.

Berk, et al

( 3) observed a profound hypoglycemia (25 mg/dl)

in dogs

5
3 hours after an LD

70

dose of endotoxin.

Filkins and

Cornell (16) elicited a drop in plasma glucose levels from
a mean control of 110 to 48 mg/dl 5 hours after the administration of s.enteritidis endotoxin to fed rats.
et al ( 5)

Berry,

injected mice with S.typhimurium endotoxin i.p.

and hypoglycemia resulted.

Intravenous injections of live

microorganisms were also shown to result in a hypoglycemic
crisis.

Griffiths, et al (26) demonstrated a decrease in

blood glucose from 90 to 70 mg/dl in dogs 4 hours following
the i.v.

injection of live E.coli.

Hinshaw, et al (31)

infused 5 baboons with live E.coli and 4 of them died in hypoglycemia.

Wichterman, et al (74) using the rat caecal

ligation and puncture model for sepsis showed an elevation
of serum glucose levels (151 mg/dl)

in early and depressed

levels (20.5 mg/dl) in late sepsis.

Hypoglycemia has also

been reported in human septic shock ( 3,55).

Rachwitz,

et al (55) documented depressed glucose levels in septic
shock patients.

Similarly, Berk, et al ( 3) reported

50 mg/dl plasma glucose value in a patient lapsing into
septic shock.

The hypoglycemia appears to be associated

with circulatory collapse and impending death.
In another study, Hinshaw, et al (33) injected an LD

70

dose (1.0-1.5 mg/kg) of E.coli endotoxin into the femoral
veins of 11 anesthetized dogs.

After 300 minutes, 8 of the

6
11 died in hypoglycemia while the 3 survivors maintained
their plasma glucose level at 61.7 ± 16 mg/dl.

A second

group of 9 dogs were treated with glucose following the endotoxin challenge and all dogs became normoglycemic and
survived.

In baboons injected with live E.coli, Hinshaw,

et al (31) showed that the animal's survival time was contingent on its ability to maintain a stable glucose level.
McNamara, et al (44) similarly showed improved cardiovascular function in endotoxic rabbits treated with an exogenous
source of glucose.

Berk, et al ( 3) maintained that glucose

was indeed necessary for the survival of an animal in endotoxemia.
MECHANISMS OF HYPOGLYCEMIA
From a metabolic point of view, three mechanisms have
been proposed to contribute to the development of hypoglycemia in the septic animal:
cogen stores,
and

(1) depletion of hepatic gly-

(2) depression of hepatic gluconeogenesis,

(3) enhanced peripheral tissue glucose oxidation.

HEPATIC GLYCOGEN DEPLETION
The initial metabolic response to a bacterial insult
is increased .sympathetic drive to promote hepatic glycogenolysis.

Evans and Zeckwer (13) injected E.coli into

adrenalectomized rabbits and observed the development of
hypoglycemia and convulsive death.

In contrast, rats with

7
their adrenal glands intact have been shown to go through,
as previously mentioned, a biphasic pattern in blood glucose levels with an early hyperglycemia and late hypoglycemia ( 6, 16).

Groves, et al (28) reported a concur-

rent drop in plasma glucose levels and hepatic glycogen
content in dogs injected with live E.coli.
( 5)

Berry, et al

found a marked carbohydrate depletion in different

strains of mice injected intraperitoneally with 2 mg of
S.typhimurium endotoxin.

Accompanying the blood sugar de-

crease (149 ± 6 mg % to 37 ± 13 mg %) were liver (5.5 ± 0.6
to 0.21 ± 0.07 percent by weight) and muscle (0.33 ± 0.06
to 0.10 ± 0.04 percent by weight)
Callum and Berry (43)

glycogen depletion.

observed a drop in liver glycogen

as early as 1 hour after treatment of mice with an LD
dose of endotoxin.

Mc-

50

Glycogen synthase activity was also

shown to be depressed in fasted endotoxic rats
as compared with fasted controls (826 ± 83).

(490 ± 54)
Filkins and

Cornell (16), likewise, demonstrated liver glycogen to
fall in both fed and fasted endotoxic rats.

Hypoglycemia

and glycogen depletion were most prominent 300 minutes post
injection.

Clearly,

the decreased inflow of glucose de-

rived from glycogen into the total body glucose pool plays
an important part in the development of hypoglycemia.

8

DEPRESSED HEPATIC GLUCONEOGENESIS
The gluconeogenic capacity of the liver is also impaired in infection and injury.

McCallum and Berry (43)

evaluated the gluconeogenic ability of the endotoxic mice's
liver through the incorporation of the
alanine 14

c -

U -

14

c into blood glucose.

14

c

label from

The total amount of

label incorporated from both alanine -

pyruvate -

2 -

14

c

U -

14

c

and

into blood glucose was significantly re-

duced by endotoxin to approximately 70% of control values

In vitro analysis on the effect

12 hours post injection.

of endotoxin on gluconeogenesis in isolated normal hepatocytes showed no significant impairment of function

(16).

If the isolated hepatocytes were harvested from endotoxin
donors,

however,

a pointed reduction in glucose production

in the presence of gluconeogenic substrates is seen (16).
Wannemacher, et al

(71)

in an extensive study of glucose

and alanine metabolism during bacterial infections in rats
and rhesus monkeys showed glucose formation from gluconeogenic substrates to be reduced.

Perfused rat livers during

acute (24 hours after injection of 10
agonal

7

(24 hours after 10 )

4

organisms)

and

stages of S.pneumoniae,

infec-

tion were able to produce only 12 ± 1.8 nmol glucose/g
liver/min in the presence of 10 mM alanine as compared with
a control value of 183 ± 20 nmol glucose/g liver/min (71).
Glucose formation from 10 mM pyruvate by isolated hepato-

9
cytes from infected donor rats was shown to be reduced 40
hours after the initial insult.
change after 24 hours.

There was no significant

Evidently, the decreased hepatic

gluconeogenic capacity is most pronounced during the
agonal stage of the infectious process.
ENHANCED PERIPHERAL TISSUE GLUCOSE OXIDATION
In addition to the impairment of input into the blood
glucose pool, there is also a derangement in the outflow,
i.e. glucose utilization.

This is the least understood of

the three aforementioned mechanisms and is the area of inquiry in this study.

Kinney (37) provided evidence to show

the greater glucose disappearance,
turnover rate,

in septic shock.

i.e. increased glucose

Long, et al (39) substan-

tiated this finding by demonstrating an increase in glucose
oxidation in septic patients.

Ryan, et al (63)

induced

general peritonitis in rats through caecal ligation and
found a 3-fold increase in the adipose tissue glucose oxidation of septic fasted rats as compared with normal
fasted controls.

The septic rat's adipose tissue pyruvate

dehydrogenase was significantly elevated with respect to
the fasted control group.

They did not show the same re-

lationship to exist in muscle tissue.
sion of U -

14

C glucose to

14

co 2

The rate of conver-

and labelled glycogen by

incubated hemidiaphragms was not significantly different
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between the fasted septic and control groups (63).

They

concluded that muscle was preferentially combusting its
own amino acids to increase the availability of glucose to
obligate organs.

Filkins and Figlewicz (17) were able to

show, however, enhanced glucose oxidation in endotoxic
hemidiaphragm, liver, spleen and epididymal fat pad.

The

difference may perhaps be attributed to the stage of shock
at which the determinations were made.

The hypoglycemia

associated with the agonal stages of sepsis was not reported by Ryan and coworkers (63).

Wichterman, et al (74)

showed this to be the case in peritonitis.

There was no

rise in soleus muscle glucose uptake in early sepsis
(6.9 ± 0.5 umoles glucose/g/hr) vs.
umoles/g/hr).

control (6.6 ± 0.4

Rats in late sepsis were, however, character-

ized by a profound hypoglycemia (20.5 ± 4.2 mg/dl), hypoinsulinemia (21 ± 5 uU/ml) and increased glucose uptake
(9.7 ± 0.6 umoles glucose/g/hr).

Wannemacher, et al

(71)

injected rats with S.pneumoniae and F.tularensis and measured the oxidation of 1 case.

14

C - glucose and 6 -

14

C - glu-

Since glucose labelled at carbon 1 measures both

the pentose phosphate shunt and Krebs cycle oxidation
rates and glucose labelled at carbon 6 measures only Krebs
cycle activity, it was possible to gauge the effects of infection via the pentose phosphate shunt.

There was an

increase in the oxidation of both labelled glucoses with the
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pentose phosphate shunt registering a greater increase.
Thus, Wannemacher and coworkers have suggested that the increase in energy utilization may be due to the increased
activity of phagocytic cells which derive their energy from
the oxidation of glucose through the pentose phosphate
Recent studies have shown that components of the

shunt.

blood itself do increase their glucose utilization in endotoxin shock (32,36,71).

Hinshaw, et al (30) have suggested

that white blood cells are the components acting as glucose
sinks in shock.
The majority of the evidence suggests that there is
a hypercatabolism of glucose by peripheral tissues.

Fil-

kins and Figlewicz (17) suggested that this may partly be
due to altered tissue responsiveness to insulin and/or
insulin-like substances.

They showed that epididymal fat

pads from endotoxic rats had increased basal glucose oxidation and, in the presence of a suprastimulatory dose in
vitro, marked responsiveness to insulin.

Ryan, et al (63)

showed heightened adipose tissue pyruvate dehydrogenase
activity and glucose oxidation in the epididymal fat pads
of rats.

This increase may be attributed to the high

levels of circulating insulin they found to be present in
the septic animal.

The agonal stage of shock is, however

characterized by hypoinsulinemia and hypercatabolism of
glucose.

It would be a worthwhile venture to investigate

12
whether the altered responsiveness described by Filkins
and Figlewicz is evident in an experimental model of general peritonitis.
In addition, there has been growing evidence that insulin-like substances may mediate the increased glucose
oxidation.

Berry ( 4) has shown that endotoxin stimulates

cellular glycolysis in a fashion similar to insulin.

Evis-

cerated rats subjected to hemorrhagic shock have been shown
to deplete the glucose pool in the absence of insulin (61).
Filkins (15) has shown that macrophage secretory products
induce the hypercatabolism of epididymal fat pads, in vitro.
Nies, et al (46) have reported kinin release in endotoxic
monkeys and Haberland (29) has shown that kinins have insulin-like effects on glucose transport.

It is conceivable

that, in shock where vascular permeability is compromised,
these products leak from the capillaries into the extracellular space and stimulate glucose transport.
One such entity is non-suppressible insulin-like
activity.

In 1941, Gellhorn, Feldman and Allen showed a

significant hypoglycemic effect to occur in hypophysectomized adrenodemedullated rats following the injection of
1 ml of human blood drawn

2~

hours after a midday meal (22).

This was the first demonstration of insulin-like activity
(ILA)

in human blood.

Insulin-like activity or insulin

13
effect was considered to be any effect obtained over and
above that produced by insulin-free solutions, such as
buffered saline, on both in vitro and in vivo systems (47).
Characterization of plasma !LA progressed after the development of more sensitive biological assay methods.
Martin, et al (41) and Renold, et al (59) developed an isolated rat adipose tissue assay, in vitro, and Gemmill (23)
and Gemmill and Hamman (24) showed the feasibility of an
isolated rat diaphragm bio-assay.
1 -

14

c -

glucose to

14

co 2

The conversion of

by rat adipose tissue was used

as the metabolic index of blood !LA.

Glucose uptake (67),

glucose consumption and glycogen deposition (23) and net
gas exchange were likewise employed.
The sensitivity, specificity and accuracy of these
bio-assay systems varied.

Estimates of plasma !LA in nor-

mal fasting man ranged from 50-350 uU/ml in a study by
Martin, et al (41) using the in vitro adipose tissue assay.
Somewhat lower range of 30-80 uU/ml was obtained through
the isolated rat diaphragm method (27,56,70).

The consist-

ently lower value for blood insulin concentration obtained
through the muscle bio-assay led numerous investigators to
suggest a greater sensitivity to insulin-like substances by
adipose tissue.
The introduction by Yalow and Berson (76) of a radio-

14
immunoassay specific for insulin yielded a more precise
serum insulin content of 20 uU/ml in the normal fasting
subject.
A survey of the estimated values of blood insulin
levels reveals a marked discrepancy to exist between bioassayable insulin-like activity (ILA) and immunologically
determined immunoreactive insulin (IRI).
was that IRI was not identical to ILA.

The consensus
It was believed

that ILA represented the cumulative biological effect of
insulin and other physicochemically distinct substances
that mimic its actions.
In 1958, Leonards (38) demonstrated that human serum
ILA was only partially suppressed, if at all, by Guinea Pig
anti Porcine Insulin Serum (GPAIS).

GPAIS is a specific

insulin inactivator which, when added in vitro to an adipose tissue or muscle preparation, blocks the stimulatory
action of insulin on glucose metabolism.

Human serum ILA

was totally suppressed with GPAIS in an isolated diaphragm
preparation (69), whereas only a partial suppression of ILA
was achieved in an adipose tissue assay (19).

Froesch,

et al (19) referred to the latter as "non-suppressible
insulin-like activity" or NSILA.

It was also called "atypi-

cal insulin" by Samaan, et al (65) and "bound" insulin by
Antoniades ( 1 ) .

The fraction of serum ILA that was in-

activated by GPAIS was called suppressible ILA,

typical and

15
free insulin ( 1 , 19, 65).

The relative ratio of NSILA to

suppressible ILA in serum was shown to be 93:7.

Only

7~~

of total serum ILA was suppressible with anti-insulin
serum in normal fasting subjects (19).
SUPPRESSIBLE INSULIN-LIKE ACTIVITY
Suppressible !LA in normal fasting humans was shown
by Froesch, et al

(19)

to be approximately 13 uU/ml.

This

basal value rose one hour after an oral glucose load to
100 uU/ml suggesting a direct relationship between suppressible ILA and plasma glucose level.

Suppressible !LA

was also shown to increase following i.v. administration of
glucose (25) or crystalline insulin (19)
jects.

into normal sub-

Elevated levels of suppressible ILA were found in

patients with active B islet cell adenomas (47) whereas
pancreatectomized dogs exhibited none at all (68).

Were

suppressible ILA and insulin one and the same as suggested
by the preceeding evidence?
(19)

A study by Froesch, et al

found a good correlation to exist between suppressible

ILA and IRI values in diabetic patients to suggest that
identity does exist.

Sonksen, et al (66)

in a study of a

large pool of sera, showed a significant correlation
(r

=

0.77, p less than .001) between suppressible !LA

and insulin measured by immunoassay.
correlation (r

=

They also showed no

0.25, p greater than .05) between NSILA

16
and immunoreactive insulin.

As a result,

it is now gen-

erally accepted that bio-assayable suppressible ILA and
IRI are indeed equivalent entities.
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY

Suppressible ILA, however, accounted for less than
10% of the total bio-assayable ILA.

Non-suppressible in-

sulin-like activity (NSILA), whose role in septic shock
hypoglycemia is of interest to us,
majority.

represents by far,

the

Like insulin, NSILA stimulated glucose uptake

and utilization in both adipose and muscle tissue.

Unlike

insulin and suppressible ILA, however, NSILA levels were
independent of blood glucose levels and were shown not to
be elevated in patients with diabetes or organic hyperinsulinism (47).

Perturbation of the B-cell system by the

addition of mannoheptulose (20) produced no alterations in
NSILA although acute changes in plasma glucose occurred.
Oral or i.v. administration of insulin also did not result
in a change in NSILA levels (47).
NSILA levels were shown to increase under conditions
of heightened energy demands.

Electrically induced muscular

hindlimb contraction of 30-minute duration resulted in a
marked increase in leg lymph NSILA (57).

Filkins (14) has

shown elevated NSILA in rats during late endotoxemia.

This

work suggested that the escalation of NSILA may be respon-

17
sible for the hyperinsulinemic state which leads to lethal
Burn or surgical trauma (52), non B-cell

hypoglycemia.

tumor hypoglycemia, such as intra-abdominal fibrosarcoma
(50) and retroperitoneal sarcoma (54) also exhibited elevated NSILA.

Froesch, et al (18) have suggested that the

physiological import of serum NSILA may be manifested only
during conditions of injury and inflammation.
Non-suppressible ILA was shown to be a heterogenous
entity (35).

Gel chromatography of NSILA yielded two pro-

tein fractions:

a main fraction with an estimated mole-

cular weight of about 100,000 daltons and a minor one (5%
of total) with an estimated molecular weight range of
6,000 - 10,000.

Only the minor fraction was soluble in

acid ethanol, hence it was called NSILA-s.
of the serum NSILA, about 80 -

The majority

90%, was precipitated by

ethanol, and this fraction was called NSILA-p.

This rather

clear distinction has since been questioned but, what is
clear is that serum contains several proteins possessing
insulin-like properties.

These include in addition to

NSILA-s, small molecular weight proteins such as somatomedins and nerve growth factors.

Poffenbarger, et al (51)

have also shown a large molecular weight protein (88,000)
with non-suppressible insulin-like activity.

He called

this "non-suppressible insulin-like protein" or NSILP.

It

has not been determined whether Poffenbarger's NSILP corre-

18
sponds to Jakob's precipitable large molecular weight fraction.
NSILA-s
NSILA-s was shown to be a heat-resistant protein that
was inactivated by base, cysteine and glutathione ( 7).
This substance is tightly bound to a carrier protein and
The active moiety

therefore normally inactive in serum.

dissociates from the complex under acidic conditions.

Rind-

erknecht and Humbel (60) were subsequently able to differentiate the NSILA-s fraction into two polypeptides of
like molecular weight

(7500).

Both protein units exhibited

non-suppressible insulin-like activity.

The amino acid

sequence of both polypeptides resembled that of proinsulin
(34).

Out of 73 amino acid positions, 45 (62%) were iden-

tical in the two polypeptides (34).

Plasma levels of these

two isomers were shown, to a general degree,
control of growth hormone (34).

to be under the

Because of their growth

promoting abilities, growth hormone dependency (somatomedin
like), and homology to insulin structure and action, these
polypeptides were termed Insulin Growth Factor I and II,
i.e.,

IGF I and IGF II (60).
NSILA-s has been shown to stimulate all aspects of

glucose metabolism in much the same manner as insulin,

The

dose response curves of NSILA-s on glucose uptake and net

19
gas exchange were shown to be parallel to those of insulin

(21).

Furthermore,

their effects were additive.

A few im-

portant differences do exist between NSILA-s and insulin.
Unlike insulin, NSILA-s or for that matter any of the serum
proteins possessing insulin-like bioactivity are,

for the

most part, not produced or stored in abundance in a specifie organ.

NSILA is not of pancreatic origin (53).

Fur-

thermore, NSILA-s has a greater binding affinity to muscle
(49) and is not inactivated by the liver (49).
(49)

Oelz, et al

injected NSILA-s and insulin intravenously in separate

experiments and found them both to result in a marked hypoglycemia.

The duration of NSILA-s' in vivo effect, however,

outlasted that of insulin.

The liver's inability to clear

NSILA-s from the blood and its greater binding affinity
contributed, no doubt,

to the longer duration.

Present evidence suggests that IGF I and IGF II
(NSILA-s) do not play a role in the normal regulation of
glucose homeostasis.

Rather they seem to be correlated

with conditions that are characterized by increased energy
expenditure, as in diseased states.

Increased levels of

NSILA-s have been shown in extrapancreatic neoplasms with
severe hypoglycemia ( 8).

It is conceivable, therefore,

that NSILA-s, although a minor fraction,

plays an im-

portant role in the provision of energy substrates to the
body's cells under abnormal conditions.
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NSILA-p

The main fraction of serum NSILA is NSILA-p.

This

large molecular weight substance is not interconvertible
with the smaller NSILA-s.

NSILA-p is a heat labile sub-

stance t h at d enatures at temperatures greater t h an 8o oc
(35) •

It mimics all of insulin's action except on gly-

cogenolysis (48).

Dose response curves of NSILA-p on net

gas exchange and glucose transport,

like NSILA-s, were

parallel and additive to insulin.
Poffenbarger (51)

isolated an 88,000 molecular weight

glycoprotein consisting of two non-identical chains of
approximately 42,000 and 46,000 daltons.

This "non-sup-

pressible insulin-like protein" or NSILP may account for a
major portion of serum NSILA.
not identical,
fraction,

It is probably similar, if

to the precipitable large molecular weight

NSILA-p,

isolated by Jakob,

et al

(35).

Conclus-

ive evidence to the contrary has not been forthcoming.
Serum ILA under normal conditions has been shown to
behave as if it were entirely composed of macromolecular
substances.

Rasia,

et al

(58) were not able to recover

serum ILA in similar concentrations in lymph, whereas
serum and lymph IRI were similar.

This behavior may be

attributed to the large size and relative proportion of the
NSILA-p molecule in the serum.

Evidently,

under normal
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situations, NSILP and other large molecular weight substances are restricted to the vascular space.

It is a well known fact that cardiovascular and
metabolic inadequacies are manifested in conditions of
infection,

injury and inflammation (11).

It is under

these conditions of altered vascular function,
increased capillary permeability,

such as

that Froesch, et al

(18)

postulated NSILA to cross the capillary membrance and come
into contact with local tissue.

This would,

in effect,

provide additional glucose to the cells in times of urgent
need.
One of the foci of this paper is to assess the role,
if any, of these substances in the blood that display nonsuppressible insulin-like activity,

in the hypoglycemia

seen in the terminal stages of septic shock.

Encouraging

evidence has already been gathered from this laboratory
implicating an increase in total NSILA levels in late endotoxemia (14).

MATERIALS AND METHODS
ANIMALS
Healthy male rats of the Holtzman strain (Holtzman
They

Company, Madison, Wi.) weighing 270-370 gm were used.
were kept on a diet of Purina Rat Chow (Ralston Purina,

St. Louis, Mo.) and water for at least a week prior to the
study.

They were acclimated to an ambient temperature of

22°C (71.6°F) and a 12-hour light-dark cycle (7:00 A.M.
7:00P.M., CST).

-

All rats were fasted overnight prior to

experimentation, unless otherwise mentioned.

Water was

provided ad libitum throughout.
SEPSIS MODEL:

CAECAL LIGATION AND PUNCTURE PROCEDURE

The method introduced by Wichterman, et al (73)

for

the induction of peritonitis in laboratory rats as a model
of sepsis was adopted and modified for the purposes of
this study.
Generally, unless otherwise mentioned,

the surgical

procedure was performed between 8:00 and 10:00 A.M. on
the day of the study.

A midline laparotomy, approximately

1-2 em in length, was done under ether anesthesia.

The

caecum was exposed and isolated from the abdominal
cavity.

Ligation of the caecum was performed just below
22
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the ileocaecal junction with a 3-0 silk ligature (Figure 1)

(73).

Intestinal continuity was later ascertained during

post-mortem examination by the unimpeded aboral flow of an
opaque dye originally injected into a region of the ileum
above the tie.

The caecum was punctured twice,

through, with an 18-gauge needle.
perforation and hence,

through and

To ensure patency of the

to hasten the infectious process,

caecal contents were expressed into the peritoneal cavity
before closure of the incision.

The abdominal muscle lay-

ers were sutured closed whereas Michel wound clips were employed to rejoin the outer skin layer.

MEASUREMENTS

The rats were divided into three groups:

(1)

rats

whose caeca were ligated and punctured (CLP), as described
above,

(2)

rats whose caeca were isolated and replaced

without being tied or perforated (SHAM), and lastly

(3)

control rats who were fasted but not subjected to surgery
(FC).

LETHALITY
CLP rats were sacrificed by decapitation after their
righting reflex was judged to be lost,

i.e.,

in the supine position without objection.

they would lie

The loss of this

reflex was used as an indication of the onset of septic
shock.

SHAM and FC animals were sacrificed at the same

24

1 Caecum
2 Colon
3

II eo- caecal junction

4

Ileum

--•
FIGURE 1.

Ligation site
Puncture site

Site of caecal ligation and puncture.
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time as the septic rats to serve as time matched controls.
CLP rats that were alive 72 hours post operation
were considered as survivors in preliminary studies.

In

successive experiments, however, the mortality rate was
determined 16 hours post surgery.

Most septic rats were

in the throes of death at this time.
Post-mortem examination agreed with the description
provided by Wichterman, et al (73) of a fluid filled abdominal cavity, engorged and gangrenous caecum, patent
caecal perforations and no visible presence of stool in the
abdomen.

Cultures done by this group showed a myriad group

of microorganisms such as Escherichia coli and Proteus
mirabilis flourishing in the peritoneal fluid

(74).

No

effort was made to identify such organisms in this study.
A qualitative determination of bacterial presence in blood
was, however, performed and resulted in a positive culture
from the septic animals.
PLASMA GLUCOSE
In the early phase of the study, plasma glucose
levels were measured prior to surgery and at 8-hour intervals,

thereafter, until the rats were sacrificed.

This

group of animals were fasted in the morning (8:00 A.M.)
and underwent surgery in the afternoon (4:00P.M.).

This
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procedure was identical to the sepsis model of Wichterman,
et al

(73).

This set of experiments sought to determine

the lethality of the model and the progression of blood
glucose disturbances.

In subsequent studies, however, only

presurgical and terminal levels of plasma glucose were
measured, as the emphasis of the study focused on glucose
dyshomeostasis during the agonal stages of septic shock.
Blood was collected prior to surgery through tail bleeds
under ether anesthesia.

At the time of death, however,

blood was obtained by decapitation.
GLUCOSE ANALYZER

Blood samples were collected in 250 ul heparinized
micro-centrifuged tubes

(Beckman Co., Lincolnwood,

over ice and centrifuged.

Il.)

Plasma glucose values, expressed

in mg of glucose per dl of blood or mg%, were obtained
directly from a glucose analyzer (Yellow Springs Instrument Model 23A, Yellow Springs, Oh.).
SERUM IRI

Blood samples were collected in centrifuge tubes over
ice at the same time points already mentioned and allowed
to clot.

Subsequent centrifugation (6,000 RPM,

IEC PR-J

centrifuge) allowed the separation of serum from the formed
elements.
was done.

Sera was stored at -20°C until radioimmunoassay
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PHADEBAS INSULIN TEST

Phadebas Insulin Test

(Pharmacia Diagnostics, Sweden)

is a radioimmunoassay based on the Sephadex solid phase
technique.

The insulin in an unknown sample is allowed to

compete with a fixed amount of an

125

I-labelled insulin for

the binding sites on highly specific insulin antibodies.
Bound and free insulin are separated by centrifugation and
washing.

The radioactivity of the bound complex is measur-

edina gamma counter (1185 Series, Nuclear Chicago).

The

amount of bound radioactivity is inversely proportional to
the amount of insulin present in the sample.

Serum IRI

values are expressed as uU of Insulin per ml of blood.

IN VITRO DETERMINATION OF GLUCOSE OXIDATION

Glucose metabolism by the rats'

epididymal fat pads

(EFP) was determined at the time of sacrifice for all three
groups:

CLP, SHAM and FC.

Criteria used for sacrifice

of the septic rat was loss of its righting reflex,

as in-

dicated earlier.
ADIPOSE TISSUE PREPARATIONS
Subsequent to sacrifice by decapitation, blood was
collected for serum IRI, PG and NSILA determinations.
peripheral segments of the rats'

epididymal fat pads

The
(EFP)

(Figure 2) were quickly excised and placed into a 30 ml
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1 Right testis
2 Fat pad
3 Cauda epididymis
4 Vas deferens
• •Sections
FIGURE 2.

Peripheral segments of rat epididymal
fat pads used in the segmental bioassay
for basal glucose oxidation, insulin
responsiveness, and non-suppressible
insulin-like activity (NSILA).
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beaker filled with 0.9% saline solution kept at room ternperature.

These EFP portions (approximate individual

weight = 500-600 mg)

wer~

reduced to several 75-125 mg

sections and pooled randomly in a petri dish containing physiological saline (53).

All EFP segments,

thereafter, were

blotted and weighed before being deposited into metabolic
(Saba)

flasks.

Two to three portions of adipose tissue

were used per incubation vessel to bring the accumulated
tissue wet weight to about 200 mg (180-225 mg range).
entire process, outlined above,

The

from the resection of the

tissues to their placement into the flasks,

took no more

than 15 minutes.

C0

2

TRAPPING APPARATUS

Shortly prior to the placement of the EFP segments
into the Saba flasks,
mixture, pH= 7.4)

5 ml of an equilibrated (95:5

o 2 ;co 2

solution of Krebs Ringer Bicarbonate

(KRB) buffer (100 ml 0.9% NaCl;

1.3% NaHC0 ) was added.
3

4 ml 1.15% KCl;

3 ml 1.22%

In addition, 100 mg of D-glucose

(Malinckrodt, St. Louis, Mo.)
(Amersham, Arlington Hts.,

and 50 ul of U-

14

C-D~glucose

Il.) were combined with the

original KRB solution to bring the final glucose concentration and specific activity in each flask to 1 mg/ml and
0.5 uCi/ml,

respective~y.

The flasks containing the incubation media were kept
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at room temperature until after the addition of the EFP
segments and a second aeration of the preparation with a
95% 0 : 5%
2

co 2

mixture for 1 minute.

The in vitro method of Saba and Diluzio (64) was
used for the collection of expired

co 2 •

The EFP segments

were incubated in capped 50 ml Saba flasks
Co., Vineland, N. J.)

(Kontes Glass

for 60 minutes at 37°C in a Dubnoff

metabolic shaker at a rate of 120 cpm.
At the end of the incubation period, scintillation
vials (Wheaton Scientific, Millville, N. J.) with 24 mm cap
diameters were fitted into Teflon adapters which,

in turn,

screwed on to the sidearm of the incubation flask.
the released

14

co 2 ,

To trap

strips of Whatman No. 52 filter paper

saturated with 0.3 ml of Hyamine hydroxide (1.0 M in Methanol, Amersham/Searle) were placed earlier in each scintillation vial.

The reaction was stopped and the

14

co 2

re-

leased by the addition of 1 ml of 62.5% citric acid solution.

Recovery of

14

co 2

was allowed to proceed for 15

minutes after which time, 15 ml of liquid scintillation
fluor

(1 L toluene; 4 gm PPO; 0.1 gm POPOP) was added to

each vial.

It has since been determined that a correction

factor is necessary to calculate the total evolved
from a 15-minute collection period.

14

co 2

Each vial was subse-

quently counted in a liquid scintillation counter (ISOCAP
300, Nuclear Chicago)

for 20 minutes.
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DATA EXPRESSION AND ANALYSIS
Data was expressed as disintegrations per minute
(DPM) of

14

co 2

recovered per gram wet weight adipose tissue

per hour of incubation.

A computer program was used to

compensate for a possible decrease in counting efficiency
due to water evaporization.

This program contructed a

sample channels ratio vs. efficiency curve based upon a
C-14 standard quench set count rate
lington Hts.,
Means,

(Amersham/Searle~

Ar-

Il.).
standard errors and analysis of variance be-

tween groups were determined using standard computer programs.
BASAL GLUCOSE OXIDATION
Procedure followed was as outlined above for in vitro
determination of glucose oxidation.
INSULIN RESPONSIVENESS
Insulin stimulated glucose oxidation by the EFP segments from septic, sham and fasted control rats was assessed and compared at the time of death.

The segmental EFP

assay was followed except for the addition of a suprastimulatory concentration of insulin (1 mu/ml).
solution was prepared fresh

Insulin

(47.3 ug crystalline insulin
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dissolved in 5 ml 0.9% NaCl) during the day of the experiment in siliconized glassware.

One hundred ul of this

solution was added to each flask.
Duplicate companion flasks without insulin were run
with a like number of insulin stimulated vessels to serve
as paired controls for each animal in any given group.
14

Data was expressed as DPM
cubation.

co 2 /gm

wet weight/hr in-

A comparison of the glucose metabolism stimu-

lated by insulin was made across the three groups.
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY

The fraction of serum insulin-like activity (ILA)

that

does not lose its activity when treated with anti insulin
serum is termed as non-suppressible ILA (NSILA)
rum was collected from septic,

(19).

Se-

sham and fasted control rats

after sacrifice by decapitation.

It was oftentimes necess-

ary to pool the rat sera, especially for the septic group
to attain the desired 1 ml of sera per 5 ml of incubation
media ratio.

The accumulated sera was stored at a temper-

ature of -20°C until needed,
The assay called for the preincubation of 1 ml of the
collected sera with 200 ul of guinea pig anti porcine insulin serum, GPAIS (Miles Laboratories, Elkhardt,

Ind.)
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for 1 hour at 37

0

c.

Following this preincubation period,

glucose oxidation was assayed as previously described with
segmented EFP from fed donor rats (wt. range: 325-350 gm).
The constituents of the incubation media were varied
to ascertain total ILA, NSILA and suppressible ILA.

Total

ILA was measured by withholding the addition of GPAIS to
the KRB-rat serum solution.

NSILA was measured by incu-

bating EFP segments in flasks containing 5 ml KRB, 1 ml rat
sera and 200 ul of GPAIS solution.

Suppressible ILA was

estimated to be the difference between the total ILA and
NSILA.
The immunological ILA or immunoreactive insulin (IRI)
was also measured in these experiments by the Phadebas
method.

RESULTS
LETHALITY
The preliminary experiments in this study mimicked
the caecal ligation and puncture method of Wichterman, et al
Surgery was performed

(73) to induce general peritonitis.

in the afternoon following an 8-hour morning fast.

Subse-

quent to the operation a 5 ml/100 gm wt. bolus of 0.9% NaCl
was injected intramuscularly.

This procedure resulted in a

58.3% (7/12) mortality rate 72 hours post operation.
second group of control rats (SHAM) showed 100% (N
vival rate 72 hours after surgery.

=

A
7) sur-

This group of rats

underwent surgery with caecal manipulation but no ligation or
puncture.
A modification of Wichterman, et al's (74) procedure,
i.e., morning surgery following an overnight fast, enlarged puncture holes, expression of caecal contents prior
to wound closure and non injection of the 0.9% saline solution resulted in a hastening of the pathological process.
Sixteen hours after surgery, 67% (35/52) of caecal ligated
and punctured (CLP) rats had expired.
fasted control (FC)

SHAM (N

=

26) and

(N = 24) rats had no lethalities.

100% mortality rate was approached 48 hours after the
surgery for the septic group.
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PLASMA GLUCOSE AND SERUM INSULIN

In the earlier experiments,
and CLP) were studied.

two groups of rats

(SHAM

Blood samples were taken 1 hour

prior to the operation and at 8-hour intervals thereafter
until the time of death or sacrifice at 72 hours, whichever
Figure 3 maps out the plasma glucose pattern

came first.

in SHAM, CLP survivors (CLP-s)
(CLP-ns).

and CLP non survivors

The SHAM and CLP-s group of rats maintained

their plasma glucose at normoglycemic levels of 100 -

120

mg/dl whereas the CLP-ns rats exhibited plummeting blood
Figure 4 illustrates the terminal glucose

glucose values.

values for the aforementioned three groups.

The CLP-ns

rats demonstrated a severe hypoglycemia (14.5 ± 4.0 mg/dl)
upon death.

In contrast CLP-s and control SHAM rats were

at normal fasting levels of 103.7 ± 6.9 and 108.7 ± 3.7,
respectively.

Subsequent experiments employed the modification of
Wichterman,

et al's

(73)

sepsis model.

A series of experi-

ments was done to measure plasma glucose levels and serum
insulin content l

hour prior to surgery and at the time of

death or sacrifice.
(2)

SHAM;

(3)

FC.

Three groups were studied:
As before,

glycemic (35.9 ± 2.7 mg/dl)

(l) CLP;

the CLP rats were hypo-

at death whereas both FC and

SHAM control groups were normoglycemic at 100 ± 1.6 mg/dl
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FIGURE 3.

Septic non-survivor

N=7

(CLP-ns)

N=7

Plasma glucose levels of sham rats and
progression to hypoglycemia of septic
rats.
See Appendix A for numerical data.
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A - All rats one hour prior to surgery
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Septic non-survivors (CLP-ns)
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Septic survivors (CLP-s)

D - Surgical control (SHAM)
FIGURE 4 .

Presurgical and terminal plasma glucose levels
in control and septic (afternoon surgery) rats.
a

b

Blood samples for septic non-survivors (CLP-ns)
were taken at the time of death;
Blood samples for septic survivors (CLP-s) and
sham operated controls (SHAM) were collected 72
hours post operation.
Data expressed as MEAN ± S.E.M.

*

CLP-ns vs. CLP-s and CLP-ns vs. SHAM.
All significant comparisons at p less than 0.05.
See Appendix A for numerical data.
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and 94.3! 3.9 mg/dl,

respectively (Figure 5).

Ligated

and punctured rats that were alive 16 hours after surgery,
likewise, demonstrated not significantly different blood
glucose value of 105.9 !

4.9 mg/dl.

Terminal serum immunoreactive insulin (IRI)
for

the three groups;

FC,

each other (Figure 6).

content

SHAM and CLP did not vary from

No significant difference was

found to exist between groups at the same time point.
There was a difference, however, between the presurgical
and terminal IRI levels.

The significance of this will be

discussed later.

BASAL GLUCOSE OXIDATION

Peripheral tissue glucose oxidation was assessed for
all three groups:

FC,

SHAM and CLP.

Table 1 illustrates

the hypoglycemia and enhanced adipose tissue glucose utilization in the agonal stages of sepsis.
of

14

c -

glucose to

14

co 2

The oxidation

by the septic rat's epididymal

fat pads was significantly greater than either SHAM or FC
control group
10

3 14

co 2

(56.3 ± 6.4 vs.

dpm/g/hr)

in vitro.

35.0 !

3.3 or 24.5 !

2.4

Although the measured glu-

case oxidation value for the SHAM group was greater than
the unoperated rats

(FC),

analysis of variance showed no

significant difference to exist.
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Presurgical and terminal plasma glucose levels
in control and septic (morning surgery) rats.
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SHAM and fasted control (FC) group blood
samples were taken after simultaneous sacrifice
with dying septic rats.
CLP survivor plasma glucose levels taken 16
hours post operation.
Data expressed as MEAN ± S.E.M.
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Significant difference at p less than 0.05.
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Presurgical and terminal serum immunoreactive insulin (IRI) concentration in
control and septic (morning surgery) rats.
Data expressed as MEAN ± S.E.M.
No significant differences between groups
at p greater than 0.05.
See Appendix C for numerical data.
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TABLE 1
IN VITRO BASAL GLUCOSE OXIDATION BY SEPTIC

AND CONTROL EPIDIDYMAL FAT PADS

Groups

Plasma Glucose

Glucose Oxidation
3 14
(10
co dpm/g/hr)

(mg/dl)

1.

2.

=

=

97 ± 2.0

35.0 ± 3.3

33

96.5 ± 2.5

FC

N

56.3 ± 6.4 a

32

SHAM

N

3.

40.2 ± 3.0 a

CLP

N

2

=

24.5 ± 2.4

32

Data expressed as MEAN ± S.E.M.
a

CLP vs. SHAM, CLP vs. FC.
ANOVA at p less than 0.05.

Significant comparisons.
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INSULIN RESPONSIVENESS

Filkins and Figlewicz (17) had shown that the adipose
tissue of endotoxic rats was hyperresponsive to a given
stimulus of insulin in vitro.

They suggested this as a

possible mechanism for the enhanced peripheral tissue glucase oxidation.

The responsiveness of the septic rat's

epididymal fat pads was assessed in this study by the adclition of a supra stimulatory concentration of insulin
(1 mU/ml) in vitro.

As mentioned earlier,

the basal glu-

case oxidation, in vitro, of adipose tissue excised from
septic rats catabolized glucose at a higher rate than
either control group
1.9 10

3 14

co 2

(42.1 ± 4.2 vs.

dpm/g/hr).

23.9 ± 2.0, 17.8 ±

Table 2 also shows that upon ad-

clition of 1 mU/ml of insulin into the incubation media,
septic rats'

the

fat pads were further stimulated to a greater

value of glucose oxidation than either SHAM or FC group.
Statistical analysis showed these differences to be signifcant.
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY

Along with the aberration of tissue responsiveness,
recent work from our laboratory has shown the possibility
of non-suppressible insulin-like activity (NSILA)

as an

important factor in glucose homeostasis in infectious
states (14).

A modification of Poffenbarger's segmental

43
TABLE 2
EFFECT OF INSULIN, IN VITRO, ON SEPTIC AND CONTROL
EPIDIDYMAL FAT PAD GLUCOSE OXIDATION

Glucose Oxidation
14
(10 3
co 2 dpm/g/hr)
PGb

Groups

(mg/dl)

1.

CLP

52.6 ± 6.9a

(18)

2.

SHAM

90.3 ± 1.8

(14)

FC

3•

93.7 ± 3.42
( 17)

Basal

c

(0 mU/ml)

42.1 ± 4.2a

(18)

Stimulated
(1 mU/ml)

c

104.7 ± 11.8a
(18)

23.9 ± 2.0

(16)

71.8 ± 11.0
(15)

17.8 ± 1.9

(16)

56.6 ± 4.9
(15)

Data expressed as MEAN ± S.E.M.
a

CLP vs.

SHAM, CLP vs. FC.

ANOVA at p less than 0.05.
b PG:

Plasma Glucose

c Insulin concentration

All significant comparisons.
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bioassay for NSILA was employed in this study.

The epi-

didymal fat pads from fed donor rats were incubated under
(1)

three separate conditions:
bonate buffer (KRB) alone,
(3) KRB
(GPAIS).

in Kreb's Ringer bicar-

(2) KRB + test serum and lastly,

+ test serum + Guinea Pig Anti Insulin Serum
The first group served as control, and the second

and third were for assessing total ILA and NSILA, respectively.

The presence of CLP, SHAM or FC sera in the media

significantly elevated the fat pad glucose oxidation (Table
3).

This indicated the presence of insulin and insulin-

like substances in the sera of all three rat groups.

IRI

was measured and no significant difference was found between the septic and control groups.

When the GPAIS was

added along with serum into the media to assess NSILA, CLP
sera demonstrated a greater level of activity than SHAM or
FC sera.

Glucose oxidation did not vary in the presence

or absence of GPAIS in either CLP or FC group.
a marked reduction, however,

There was

if GPAIS was added to a prep-

aration with sera from SHAM rats.

The relevance of these

observations will be discussed in the next section.
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TABLE 3
COMPARISON OF NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY
IN THE SERA OF SEPTIC AND CONTROL RATS
Glucose Oxidationc
(10

IRib,d
(uU/ml)

GROUPS

3 14

co 2

dpm/g/hr)

KRB +
serum

KRB
only

KRL + SERUM
+ GPAIS

1

CLP

32.8 ± 3.6

18.8 :t 2.0

( 8)

(10)

84.1 :: 9. 9
(

7)

88.5 ± 8.0a
(7)

38.2 ± 1.5
(63)
2

SHAM

90.0 ± 13.5

90.6 ± 3.3

15.6 ± 1. 3

(12)

(10)

(11)

92.4 ± 4.0

14.4 ± 1.1

48.3 ± 6.0

67.8 ± 5.2a
(26)

3

FC

(10)

(10)

(11)

Data expressed as MEAN ± S.E.H.
a

CLP vs. SHAH, CLP vs. FC, SHAM vs. FC. All significant
comparisons ANOVA at p less than 0.05.

b

No significant difference in IRI, p greater than 0.05,

c Numbers in parentheses denote number of assays run.
d Numbers in parentheses denote number of animals

50.8 ± 4.0a
(28)
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DISCUSSION
SEPSIS MODEL EFFICACY
The effectiveness of the caecal ligation and puncture
(CLP) model to induce peritonitis was assessed through the
lethality rate and incidence of hypoglycemia.

As stated

earlier, 67% of CLP rats died 16 hours post surgery.

This

was comparable to a 75% (138/184) mortality rate reported
by Wichterman, Baue and Chaudry (73) for similarly treated
rats (caecal ligation + 2 punctures with an 18-gauge needle)
after 24 hours.

In the present modification of their model,

the majority of the animals died 8 - 16 hours following the
surgery.

This model is significantly more rapid and lethal

than the model Wichterman, et al (73)

first proposed.

PLASMA GLUCOSE AND SERUM INSULIN LEVELS
As illustrated by both Figures 4 and 5, the septic rats
died in a state of metabolic decompensation, viz., hypoglycemia.

Although CLP (caecal ligation and puncture) rats

that underwent morning surgery showed a less severe hypoglycemia (35.9 ± 2.7 mg/dl)

than their afternoon counterpart

(14.5 ± 4.0), the former was the method of choice because
of sampling ease since the bulk of deaths

(67%)

(35/52) oc-
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curred within a narrow time period (8 -

16 hours post sur-

The measurement of low blood glucose agrees well

gerv).

with previous works in the literature for rats in the agonal or hvpodvnanic sta?.es of endotoxemia and sepsis

(14.74).

It can also be seen from Figures 3. 4 and 5 that

the survival of an animal was reflected bv his abilitv to
maintain a status of normoglvcemia.

These data concur with

work bv Hinshaw. et al (31) and Filkins and Cornell (16).
Figure 6 illustrates that no significant difference
existed between the three grouns of animals (CLP.
FC)

in serum insulin content at the time of death.

SHAM and
There

was. however. a difference in insulin levels when the terminal readings for the three groups of animals were compared
to pre-surgical levels.

This difference may be due to the

slightly higher level of plasma glucose before surgery and
also to the blood sampling method under ether anesthesia.
Furthermore, pre-surgical glucose and insulin levels were
taken at a point closer in time to the initial withholding
of food than terminal samples.
This finding of no significant difference between control (SHAM and FC) and septic (CLP)

rats'

insulin content

does not fully agree with previous work by Ryan, et a! (16)
and Filkins (14).

Ryan,

et al

(16)

found 72 hours septic

fasted rats to have a threefold higher level of insulin
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than 72-hour fasted control rats.

A recent study by Fil-

kins (14) showed the opposite to be true in late endotoxic
shock.

He showed a hypoinsulinemia (9.2 ± 3.8 uU/ml vs.

control value of 36 ± 6) to occur prior to the animal's
death.

The difference in measured insulin concentration

between this study and those previously mentioned may be
due to a number of factors such as:

(1) mode of induction

of infection (caecal ligation vs. caecal ligation and puncture vs. endotoxin injection), and (2) stage of progression
of the infectious process.

Ryan, et al (63)

showed no hypo-

glycemia to exist in their study, whereas Filkins (14) demonstrated blood glucose levels of 41 ± 8 mg/dl.

It seems

evident, therefore, that Ryan, et al's results were taken
prior to metabolic decompensation whereas this study's results and Filkins (14) were taken during the hypoglycemic
depression.

Wichterman, et al (74) measured insulin con-

tent to be 21 ± 5 uU/ml in rats in late sepsis and this
agrees well with this study's insulin quantitation.
ENHANCED PERIPHERAL TISSUE GLUCOSE OXIDATION
Numerous studies in the past have repeatedly shown
the hypercatabolism of glucose during the infectious process (17,63,71).

This increased utilization of glucose

appears early on in endotoxicosis as a result of hyperglycemia and associated hyperinsulinemia (6).

Ryan, et al
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(63) has similarly shown this to occur in the fat pads of
septic rats.

The hypercatabolism of glucose continues,

however, until the later stages of endotoxic or septic
shock (17,32,71).

The result of this study provides fur-

ther evidence for the hypoglycemic action of increased glucose utilization.
dation of

14

c -

Table 1 shows the markedly greater oxi-

glucose to

14

co 2

and associated hypogly-

cemia in septic animals.
Two mechanisms for this hypercatabolism suggested by
Filkins and Figlewicz (17) and Filkins (14) were investigated further in this study;

(1)

tissue hyperresponsiveness

to insulin and (2) non-suppressible insulin-like activity.
INSULIN RESPONSIVENESS
The responsiveness of the septic rats' adipose tissue
was ascertained, in vitro, by the addition of a suprastimulatory dose (1 mU/ml) of insulin to the incubation media.
Table 2 shows that the added insulin stimulus drives the
septic (CLP), sham operated (SHAM) and fasted control
rats'

(FC)

fat pads to approximately three times the basal level.

Insulin further stimulated the already hypercatabolic septic rats'

fat pads such that, empirically, both basal and

stimulated glucose oxidation rates for the CLP group were
significantly greater than SHAM or FC.

This in itself does

not indicate an altered sensitivity by the septic rats'

50

adipose tissue to insulin.

These results, however, agree

with the findings of Filkins and Figlewicz (17) of increased adipose tissue insulin responsiveness in endotoxic
rats.

One of the criteria satisfied to imply an alteration

in insulin responsivity has been the antagonism of insulin
action by ATP.

Chang and Cuatrecasas ( 9) had shown that

the addition of 10- 4 and 10-S M ATP to the incubation media
decreased the responsiveness of isolated adipocytes to
insulin.

This in vitro experiment was not done in this

study, however, an in vivo study by Chaudry, et al (10) had
already shown, using the same experimental model of sepsis,
the prevention of hypoglycemia and increased survivability
following the administration of ATJ-MgC1

2

and glucose.

It

is not unreasonable, therefore, to cautiously suggest that
adipose tissue insulin responsiveness is altered in septic
as well as endotoxic shock.
NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY (NSILA)
Serum contains several proteins possessing insulinlike properties.

One of these entities, non-suppressible

insulin-like activity (NSILA) is of interest in this study
since Filkins (14) showed increased levels of NSILA associated with the terminal hypoglycemia in endotoxicosis.

The

NSILA assay employed in this study did not make any distinction between soluble (NSILA-s) and precipitable (NSILA-p)
portions.
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Table 3 illustrates significant insulin-like activity
(ILA) in serum after its addition to the incubation media.
Total serum ILA may be gauged by comparing glucose oxidation rates between assays in the presence and absence of
serum in the incubation media.

As Table 3 shows, sera from

rats that underwent surgery, CLP and SHAM, exhibited greater total ILA activity than fasted and hydrated (FC) rats.
This may be attributed to the slightly higher values of
immunoreactive insulin (IRI) and NSILA in the former two
groups.

Statistical testing shows, however, no significant

difference to exist in insulin content.

One notices that

these insulin values are lower than what was previously reported in this study.

This discrepancy is perhaps due to

variation within this strain since all the animals in this
shipment demonstrated lower serum insulin content.
All three groups of rats exhibited non-suppressible
insulin-like activity as illustrated by the increase in glucose oxidation despite the presence of Guinea Pig Anti Porcine Insulin Serum (GPAIS)

in the media.

in descending order, is as follows:

The level of NSILA,

CLP, SHAM and FC.

These results support Filkins' finding of increased NSILA
levels in the late stages of endotoxic shock (14).

NSILA

has been associated with hypoglycemia in various disease
processes ( 8 , 45).

Froesch, et al (47) have suggested a
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probable role for NSILA in the provision of energy substrates in conditions of vascular collapse.

Since sepsis

and endotoxemia both involve vascular as well as metabolic
lesions, it is a plausible supposition that NSILA as well
as altered tissue insulin responsiveness play a deciding
role in the progression to hypoglycemia.

The hypothesis

extended here is that the hypoglycemia seen in the agonal
stages of sepsis may,

in part, be attributed to an in-

crease in the level of substances in the blood and interstitial spaces which are physicochemically distinct, yet
bioactively similar to insulin.
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SUMMARY OF CONCLUSIONS

1.

Induction of septic shock through caecal ligation
and puncture is a sufficiently lethal and appropriate model for metabolic studies in infectious
processes.

2.

Late stage of sepsis was characterized by hypoglycemia.

Normal blood glucose level is correlated

to the survival of an animal after a septic
episode.

3.

There was no demonstrable difference in the serum
insulin concentration of septic, sham operated
and fasted control rats at the time of death.

4.

There was a significantly higher rate of glucose
oxidation in septic adipose tissue as compared to
sham operated and fasted control rats.

5.

Addition of insulin, in vitro, equally led to a
threefold increase in glucose oxidation rates by
the fat pads from all three groups.

6.

Increased level of NSILA in septic rats as compared to both control groups suggest a prominent
role for NSILA in the development of hypoglycemia.
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APPENDIX A

PRESURGICAL AND TERMINAL PLASMA GLUCOSE LEVELS IN
CONTROL AND SEPTIC (AFTER.NOON SURGERY) RATS

Plasma Glucose
(mg/dl)
All Rats
One Hour
Preoperation

Groups

1.

CLP-ns
(N=7)

2•

CLP-s
(n=5)

3.

SHAM
(N=7)

Terminal

14.5 ± 4.0

151.5 :!: 5. 7
(N=l9)

103.7 ± 6. 9

108.7 ± 3. 7

Data expressed as MEAN

:!:

S.E.M.

CLP-ns

Septic non-survivor group

CLP-s

Septic survivor group

SHAM

Surgical control group

a CLP-ns vs.

CLP-s and CLP-ns vs.

SHAM : Significant

comparisons through analysis of variance, p less
than 0.05.
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APPENDIX B

70
APPENDIX B
PRESURGICAL AND TERMINAL BLOOD GLUCOSE LEVELS
IN CONTROL AND SEPTIC (MORNING SURGERY) RATS

Plasma Glucose
All Rats
One Hour
Preoperation

Groups
1.

CLP-ns
(N-35)

2.

CLP-s
(N=l7)

3.

SHAM
(N=26)

4.

FC
(N=24)

Terminal
35.9 ± 2.7a

105.9 ± 4.9
108.6 ± 1.03
(N=l02)

94.3 ± 3. 9

101.0 ± 1.6

Data expressed as MEAN ± S.E.M.
FC : Fasted control group
a

CLP-ns vs. CLP-s, CLP-ns vs. SHAM, CLP-ns vs.
FC : All significant comparisons through
ANOVA, p less than 0.05.
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APPENDIX C

72
APPENDIX C
PRESURGICAL AND TERMINAL SERUM IMMUNOREACTIVE
INSULIN CONCENTRATION IN SEPTIC (MORNING
SURGERY) NON-SURVIVOR AND CONTROL RATS
Serum Immunoreactive Insulin
(uU/ml)
All Rats
One Hour
Preoperation

Groups

1.

CLP

2.

SHAN

3.

FC

Terminal

24.7 ± 2. 5

33.3 ± 2. 1
(N=40)

24.5 ± 2. 7
(N=21)
22.1 ± 2.4
(N=22)

Data expressed as MEAN ± S.E.M.
CLP : Septic non-survivor group.
No significant difference
Anova less than 0.05.

bet~een

groups.
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